EY 128 small molecule data

TELR said Phase I/II results in 36 patients showed the agent to be well tolerated and to lessen surgical miosis, the decreased pupil size associated with the phacoemulsification procedure used to remove cataracts.

Groups of 12 patients received a high or low dose of the agent, or placebo, intraocularly. Doses of the agent, and its identity, are not being disclosed. ...